Avidity Partners Management »

Align Technology shares owned by Avidity Partners Management

Quarter-by-quarter ownership of Align Technology (ALGN) shares owned by Avidity Partners Management from 13F filings

Historical chart of Avidity Partners Management investment in Align Technology

Tip: Access up to 7 years of quarterly data

All positions including Align Technology held by Avidity Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Align Technology by Avidity Partners Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $43M 156k 274.00

More positions owned by Avidity Partners Management

Arvinas Ord (ARVN)
Boston Scientific Corporation (BSX)
Cigna Corp Call Option (CI)
Thermo Fisher Scientific (TMO)
Acadia Healthcare (ACHC)
Neurocrine Biosciences (NBIX)
Syndax Pharmaceuticals (SNDX)
Natera (NTRA)
Structure Therapeutics Sponsored Ads (GPCR)
Danaher Corporation (DHR)
Tenet Healthcare Corp Com New (THC)
Karuna Therapeutics Ord
Fusion Pharmaceuticals (FUSN)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Regeneron Pharmaceuticals (REGN)

View all positions for Avidity Partners Management

Top funds holding Align Technology

Vanguard Group
Jpmorgan Chase & Co
Wellington Management Company
Alliancebernstein
Polen Capital Management
Brown Advisory Holdings Incorporated
Investec Asset Management
Bank of New York Mellon
Citadel Advisors
Millennium Management
Norges Bank Investment Management
Allianz Asset Management
Bares Capital Management
Legal & General Group
Amundi

View all funds holding Align Technology